Clinical Trial Details
— Status: Terminated
Administrative data
| NCT number |
NCT00155636 |
| Other study ID # |
5287 |
| Secondary ID |
NHRI-EX91-9113PP |
| Status |
Terminated |
| Phase |
N/A
|
| First received |
September 9, 2005 |
| Last updated |
November 25, 2005 |
| Start date |
January 2002 |
| Est. completion date |
December 2005 |
Study information
| Verified date |
January 2002 |
| Source |
National Taiwan University Hospital |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
Taiwan: Department of Health |
| Study type |
Observational
|
Clinical Trial Summary
This PPG entitled “A Study on Etiological Factors of Schizophrenia” (SEFOS) focuses on
searching for the separate etiological factors under the understanding that schizophrenia is
a complex disorder. Multifactorial model has been most often proposed as the etiological
model. Up to now, fragmented knowledge of etiological factors, including genetic factor and
environmental insults were reported in literature, and a two-strike hypothesis has been
proposed. This PPG of SEFOS formulates a dynamic etiological hypothesis of schizophrenia.
Specific, however heterogeneous, genes are hypothesized to be located in chromosome 1q, 6P,
8P, 15q, and 22q; specific environmental insults or stress are hypothesized to be acting in
the vulnerable brain a long different stages of biological and/or psychological development.
The interaction of specific genes and specific environment insults/stress along different
stages of development will result in specific neurobiological abnormalities as shown in
neuropsychological, neurophysiological and neurochemical/neuroimaging abnormalities. For
this hypothesis testing, this PPG of SEFOS designs 3 projects of: (1) A Study on
Neurobiology of Schizophrenia; (2) A Study on Environmental insults/stress of schizophrenia;
and (3) Molecular Genetics Study of Schizophrenia. Project No.1 aims at finding different
levels of neurobiological and anatomical abnormalities; Project No.2 aims at finding
different levels of environmental insults/ stress; Project No.3 aims at locating
vulnerability genes in different chromosome regions. A core unit for administrative
integration, for case/family recruitment and statistical analysis is also designed. The
dynamic etiological complex will be explored under multivariate statistical analysis. This
PPG of SEFOS adopts multidisciplinary approach including clinical psychiatrists,
psychopathologists, neuropsychologist, neurophysiologist, neuroimaging (magnetic resonance
imaging) specialist, genetic epidemiologist, molecular genetic specialist, genetic
statistician, and biostatisticians. This team has sound mutual trust base on the experience
of being working together and attending regular research meeting for the part several years
under the leadership of the principal investigator of this PPG.
Description:
Progress Report Schizophrenia is a chronic and devastating major psychiatric disorder. It
costs a lot of the individual patient, the family as well as the society. Schizophrenic
patients occupy around 80% of the chronic psychiatric beds. About 60 % of the acute
psychiatric beds serve the schizophrenic patients at severe aggravating state of illness.
The majority of the schizophrenic patients need the support of the family for their daily
life. For better service of these patients, their family as well as for reducing social
stigma of schizophrenia patients, more psychopathological understanding is crucial. However,
schizophrenia is a complex disorder. For the past one century, the understanding of
schizophrenia improved much. In Taiwan, the psychopathological study on schizophrenia
deserves basic and systematic approach for clinical and academic purpose.
Before it could be possible to understand the essence of the psychopathology of
schizophrenia, the descriptive psychopathology has to be well documented. The heterogeneity
at the level of clinical pathology has to be delineated as the initial step of
psychopathological study of schizophrenia. This is crucial under the consideration of
cross-cultural application of diagnostic criteria in the definition of schizophrenia. The
psychopathology of the disease category of schizophrenia as defined by the DSM-IV system was
documented mainly by the literature based on the descriptive study of the patients of the
Caucasian population and the related culture. Western medicine in Taiwan is totally accepted
in the academic circle. From a cross-cultural point of view, this way of academic operation
has to be reflected methodologically and to be examined empirically.
Research on schizophrenia psychopathology has to be of two kinds of value. The first is to
be of the frontier academic work of the World Psychiatry, and the study results can
contribute to the knowledge of the World Psychiatry Literature. The second is to be of
native cultural value. The results could be of value in reflecting the native cultural
reality and could be of value in application of these study results to clinical service.
To be at the frontier of schizophrenia research, the neuropsychological impairments
underlined the clinical manifestations of schizophrenia is one major area of study. In
contrast to the traditional theory of psychological defense mechanism or the psychosocial
explanation of psychopathology of schizophrenia, the neuropsychological approach could
provide the way to understand the neural mechanism of schizophrenia psychopathology at the
level of psychological function. In the era of neuroscience achievement, this approach is
promising and crucial.
The most basic psychopathology of schizophrenia is the genetic factor of etiology. In the
era of molecular medicine, the genetic epidemiological and molecular genetic study on
schizophrenia psychopathology is the most frontier line of schizophrenia research.
This research team leaded by the Principal Investigator, Hai-Gwo Hwu, of this PPG began this
approach in July 1993. The initial work started with the Multidimensional Psychopathological
Group Research Project: Schizophrenia” (MPGRP). This MPGRP was designed based on the
theoretical evolutionary model (EM) of psychopathology invented by this Principal
Investigator. This EM model included multiple psychopathological factors including genetic
factors, brain insults, chronic developmental life experience, neurobiological
manifestations, personality-adjustment factor, environmental stress of biological and
psychological factors, familial social cultural value factor and the factor of treatment. In
this EM model, the disease course was hypothesized into three phases: initial subclinical
stage, clinical stage, and the outcome stage after treatment. This MPGRP was thus designed
following the guidance of EM psychopathological model.
To design the psychopathological study based on this EM of psychopathology, it is necessary
to invent a new methodological approach. This approach included serial multi-dimensional
study design. The first step was to set-up a smooth infrastructure and to collect a cohort
of clinical schizophrenia cases for follow-up study, and also to collect schizophrenia
family with at least two siblings affected with schizophrenia for molecular genetic study.
This first step also considered that the descriptive psychopathological study, the study on
search for a biological trait marker and the search for identification of linkage of
possible vulnerability genetic markers of schizophrenia as the major research tasks.
The initial project started as the MPGRP from July 1993 till June 1998, the subsequent
project following the initial MPGRP, was the Multidimensional Psychopathological Study on
Schizophrenia (MPSS) started in July 1998 till June 2001. The focus of the MPGRP was to
study the clinical manifestations of schizophrenia and the family situation in a cohort of
schizophrenia patients. The MPGRP also focused on the phenotype definition of schizophrenia
using CPT manifestation in the schizophrenia family. CPT was done in all of the family of
schizophrenic patients. The family with at least two siblings affected with schizophrenia
were collected for molecular genetic study.
In the MPSS project, the focus was on the follow-up neuropsychological evaluation of the
schizophrenia cohort collected in the MPGRP, other than the descriptive follow-up clinical
data collection. Besides, the MPSS also focus on the CPT and WCST studies on the family
members o the family with at last two siblings affected with schizophrenia. These families
are also the sample for molecular genetic study. The collection of the schizophrenia family
of this kind for molecular genetic study is still the work of this MPSS, as the collection
of this kind of family was not an easy task.
There are several important features characterize the uniqueness of this MPGRP and MPSS :
(1) a prospective follow-up design, (2) multidisciplinary approach, (3) multi-center,
multi-hospital approach, (4) operationalized assessment of schizophrenia psychopathology
using the “Positive and Negative Syndrome Scale” (PANSS)(4), (5) covering multi-dimensional
psychopathological factors, (6) representing up-to-date psychopathological study of
phenotype definition, molecular genetic study, neuropsychological study, as well as the
study on the expressed emotion of the chief care giver and the family burden and need of
care of the patients.
This MPGRP and the MPSS were successfully carried out from July 1993 to March 2001(up to the
time of sending this SEFOS proposal as the subsequent study on the pathogenesis of
schizophrenia, a further step of psychopathological study on schizophrenia) based on the
following facts:
1. This MPGRP and the MPSS made the multidisciplinary team to be possible in
psychopathological study in Taiwan. This is not an easy task. Other than the technological
breakthrough in research administration in this manner, the successful element was that this
multidisciplinary approach made a smooth working infrastructure for this psychopathological
research for successive research works. Other than research work itself, the attending
members of this research team obtained continuous training and exercise in
psychopathological study. These achievements cannot be demonstrated in literature
publication.
2. This MPGRP and the MPSS made the multi-center, multi-hospital approach came true in
Taiwan in psychopathological study. This institutional infrastructure guarantee that the
sampling of schizophrenic cases to be more representative of patient population for
psychopathological study. Other than research administration breakthrough, this approach
provided a great chance for clinical psychiatrist to participate in training and practice in
psychopathological basic training. Besides, the clinical service team members, other than
psychiatrist, including psychiatric nurse, psychologist, psychiatric social worker can
obtain the common sense understanding of general psychopathological approach in psychiatry.
This close team approach will make the service team to be more cohesive in the care of the
patients. The patients attending this study would obtain more attention from the psychiatric
service team leaded by the research psychiatrist, especially in the successive follow-up
study. This is crucial in elevating the professional activity in a positive sense embedded
in this MPGRP and MPSS research. This is also one achievement of this MPGRP and MPSS in the
infrastructure of this research approach. These achievements cannot be demonstrated in
literature publication, but can be demonstrated in daily research and practice activities.
It can also be shown in the subsequent research activities such as this SEFOS project.
3. This MPRP and MPSS brought the Taiwan Psychiatry to the frontier line of
psychopathological study and contribute new knowledge to schizophrenia literature. Besides,
this MPGRP and MPSS also took care of the standpoint of the native culture background. The
descriptive phenomenological approach is the essence of operationalized psychopathological
study. The cross-cultural modification and justification of the Western rating schedule of
the PANSS has been considered and successfully done.
4. The family of schizophrenic patent was also the major area of study based on the
characteristics of the Taiwan culture. The family took the responsibility of patient care
closely. The burden and the need of patient care are important topic of this study. Besides,
taking the advantage of the culture background of the close family tie of the patient and
the family, genetic study of schizophrenia including genetic epidemiology and molecular
genetics is one major task of this MGRP and the MPSS too.
5. Major academic achievements of the track of this PPG and the MPSS psychopathological
study in these past 7 to 8 years included the following:
1. The findings of different symptom clusters of schizophrenia:
Categorical or dimensional approach of schizophrenia psychopathology is still a current
unsolved issue in schizophrenia research. The MPGRP collected 234 schizophrenia
subjects in the Northern part of Taiwan and designed a cohort follow-up study in 1993.
At the end of this MPGRP, ranged from1998 to 2000 for data analysis, the descriptive
psychopathological PANSS data assessed on admission were analyzed using explorative
factor analysis (EFA) and confirmatory factor analysis (CFA), and a basic 4-
dimensional model of schizophrenia psychopathology was established. These 4 dimensions
are: “Negative and associated Negative symptoms”, “Disorganized thought”,
“Hostility/excitement”, and “Delusion/hallucination”. Including the general
psychopathological section of the PANSS, there is an additional dimension of
anxiety/depression was found in the EFA. The CFA cannot found satisfactorily model for
model fitting as the general psychopathology section was included in CFA. This could be
due to the high variability and low base rates of these items of the general
psychopathological section of PANSS. Besides, this could also be due to the peripheral
nature of these symptom items in schizophrenia psychopathology.
These findings were confirmed by another statistical graphic approach, the color
graphic generalized association plots (GAP) in delineating the heterogeneity of
descriptive symptom pathology of the schizophrenia. In this GAP analysis, again a
4-dimension model was also found based on the PANSS data assessed on admission. These 4
dimensions were also arranged according to the proximity matrix and were revealed as
the following order: (1) “Negative symptom”, (2) “Disorganized thought”, (3)
“Hostility/Excitement”. (4) “Delusion/hallucination” dimensions. The possible dimension
of “Anxiety/depression” was also observed near the end of the dimension of “Negative
symptom dimension”.
The validity of these symptom dimensions was assessed using the impairment of sustained
attention assessed by continuous performance test (CPT). It was found that the negative
symptom dimension was associated with impaired CPT. Furthermore, the severely impaired
(Z>3.0) d’ of CPT was found to be associated with persistent negative symptom, the
deficit state of clinical psychopathology, of schizophrenia. The delusion/hallucination
dimension was found to be associated with the impaired neuronal activity of hippocampal
region measured by the neuroimaging technology of Magnetic Resonance Spectrometry
(MRS).
The GAP analysis based on the successive PANSS data assessed on admission, 6-month,
1-year and 2-year follow-up also showed a stable 5-dimension model of psychopathology.
The component symptom dimensions were the same as that of the data assesses on
admission. These are dimensions of “Negative symptom”, “Disorganized thought”,
“Hostility/excitement”, “Delusion/hallucination” and “Anxiety/depression”. This
research team developed the concept of core symptom dimension by selecting the stable
symptom items appeared stably over the all follow up course over 4 successive
assessments across the 2-year follow-up. The validity of these core psychopathological
dimensions composed of core, stable symptom cluster items is still under investigation.
2. The findings of different subgroups of schizophrenia patients:
Based on the cohort follow-up design, it is possible to search the possibility of the
existence of different subgroups of patients be categorical approach. Matched with the
effort on differentiating the symptom dimensions of psychopathology, it is also
possible to define the different subgroups of patients based on the composition of
symptom dimensions. This research team invented this analytical approach called as the
GAP analysis for this purpose. The results were partly shown in the website:
http://gap.stat.sinica.edu.tw. Based on the admission PANSS data, this GAP found 4
symptom clusters of “Negative symptom”, “Disorganized thought”, “Hostility/excitement”,
and “Delusion/hallucination”, and also two subgroups of patients with (GWNEG) and
without (GONEG) marked negative symptoms. These two groups of patients were found to
have validity from the manifestation of clinical symptom dimensions in the follow-up
course and CPT performance. Besides, these two subgroups also differed in the treatment
response an prognostic outcome as shown in social functions.
The GAP analysis, based on the follow-up data of PANSS assessment, can also find
consistently a 4 -dimensional model of schizophrenia psychopathology. One additional
dimension of anxiety/depression was also found. The patient subgrouping consistently
found three patient subgroups at 6-month, 1-year and 2-year follow-up. One is of low
psychopathology group (good treatment response group), the other is of marked blunt
group and the last is of persistent delusion/hallucination group. The concordance of
the GWNEG and GONEG and these three groups are still under investigation.
3. Impaired sustained attention by continuous performance test (CPT) as the trait marker
of schizophrenia.
We used a CPT machine from Sunrise Systems, version 2.20 (Pembroke, MA, USA). The
procedure has been described in detail I our publications. Briefly, numbers from 0 to 9
were randomly presented for 50 milliseconds each, at a rate of one per second. Each
subject undertook two CPT sessions: the undegraded 1-9 task and the degraded 1-9 task.
The sensitivity index (d) of the CPT performance reflects the subject's sustained
attention. Family studies have indicated that sustained attention deficits as measured
by the CPT are vulnerability markers of schizophrenia. The results are: (1) a
substantial proportion of non-psychotic relatives of schizophrenia probands (19-34%)
have CPT deficits, which can be predicted from their probands’ CPT performance; (2)
subjects with schizotypal personality features also exhibit CPT deficits, which are
specifically associated with negative factors of schizotypy; (3) CPT deficits are
present in schizophrenic patients, are particularly associated with negative and
disorganized symptoms, and those with more difficult CPT versions are not amenable to
neuroleptic treatment.
4. The familial tendency of schizophrenia in Taiwan schizophrenia proband In this MPGRP
and MPSS stdy, the Diagnostic Interview Schedule for Genetic Study (DIGS) and
schizotypy interview schedule (SIS) were translated and modified to be useful in Taiwan
subjects. The Perceptual aberration scale (PAS) and Schizotypal personality
questionnaire (SPQ) were also used in community study on schizophrenia-related
personality disorders. The cross-cultural consideration was employed. In community
study, the schizophrenia-related personality disorders were assessed using the PAS and
SPQ initially and then by DIGS and SIS interview. Including schizophrenia-related
personality disorder in the spectrum did not increase power for linkage analysis o
schizophrenia. This is one important information for our molecular genetic study of
this MPGRP and MPSS.
5. Explorative neurobiological study on the schizophrenic samples of this MPGRP and the
MPSS project.
The neuropsychological study of the MPSS design and the impact of the concept of
endophenotype of molecular genetic study induce this MPSS research team to explore the
role of the neurophysiological parameter of P50 inhibition and the neurochemical
parameter of neuronal activity shown in Magnetic Resonance Imaging Spectrometry (MRS)
of relative concentrations of various specific biochemical molecules such as choline
and creatinine.
The P50 study and the related neurophysiological study provided the chance to study the
implicit and explicit study paradigm of schizophrenia. The implicit learning of color
in schizophrenia was fond to be significantly impaired as compared to the controls. The
3-D dimension display of brain energy in this P50 study showed that the energy
distribution of the schizophrenic patients was significantly different from that of the
controls. The MRS study showed that the positive symptom cluster was correlated to the
decreased neuronal activity of the hippocampal region. These study results make it
possible for this research tem to design the research on the all family members of the
schizophrenia proband for pathogenesis genetic study on multi-etiological factors and
their interaction by using these neurobiological parameters designed in this SEFOS, an
investigation on the dynamic pathogenetic process of schizophrenia, leaded by this
Principal Investigator with smooth working infrastructure for multidimensional
psychopathological study on schizophrenia.
6. Molecular genetic study on locating vulnerability gene in different chromosome regions.
Linkage study and association study were performed in this project for locating the
vulnerability genes of schizophrenia by examining the warm spots of schizophrenia in
some chromosome regions of chromosome 1q, 6p, 8p, and 15q. The study results, so far
obtained in this laboratory using 52 Taiwanese families with at least 2 siblings
affected with schizophrenia, could not exclude the possible existence of the
schizophrenia vulnerability genes locations in these chromosome regions.
Further study of the PPG of SEFOS will focus on these positions of these 5 markers with
potential linkage to find closer genetic markers possibly linked with schizophrenia
using closer genetic markers such as the combination of dinucleotide and SNP markers.
The candidate genes around these genetic markers will also be explored to search for
mutations related to the pathological variation of schizophrenia. This will be the
focus of this PPG of SEFOS too following this MPGRP and MPSS.
This laboratory is exploring for the possibility of the candidate gene approach based
on plausible animal model of schizophrenia and/or pathophysiological process of
schizophrenia. The NMDA subunit R1 receptor gene and nicotinic receptor alpha 7 subtype
genes are two genes under exploration. The skin test of niacin test was also explored
in this laboratory for the possible association with genetic defect in the phospholipid
metabolism related genes. These will be included in this PPG of SEFOS study in the
future.
7. Expressed emotion and burden of the family of schizophrenic patients The family as a
unit of study is also concerned in this MPGRP and the MPSS. The expressed emotion was
once considered to be a stable trait of the family chief caregiver and was hypothesized
to have specific psychopathological meaning in schizophrenia. However, the expressed
emotion of the Taiwanese schizophrenia family was found to be changing according the
course of illness. It was not stable. The family burden was found to be very high and
specific clinical measures for relieving thee family burden has to be designed for
better clinical service of the schizophrenia family.
8. Invention of statistical method for psychopathological study The multivariate nature of
the psychopathological data demands the invention of novel statistical method for data
management. In this MPGRP and the MPSS, the analysis of 33 PANSS symptoms and the
subgrouping of the patients in the study of schizophrenia heterogeneity invite a
development of the new color graphic approach in the exploration of symptom dimensions
and patent subgrouping. This was named as Generalized Association Plots (GAP). This
demonstrates the fruitful approach in the multi-disciplinary team-work in the
psychopathological study.
9. Data bank establishment of this MPGRP and the MPSS. In the past 7 to 8 years of the
MPGRP and MPSS work, important data banks of clinical psychopathology of schizophrenia
were established. These data banks will be useful for successive data analysis to test
the various hypotheses related to the issues of heterogeneity of schizophrenia. These
data banks included (1) basic clinical data bank of schizophrenia cohort of 234 cases
and their follow-up clinical data for up to 7 years of follow-up data, (2) data bank of
objective ratings of PANSS, ESRS, and CDRS, and (3) neuropsychological testing data
bank of successive follow-up neuropsychological evaluations. The DNA bank and cell-line
bank of the families of schizophrenia and other related disorders is also very
important for further molecular genetic evaluation.
Other than this DNA data bank of this MPGRP and MPSS, this laboratory also performed the
Taiwan Schizophrenia Linkage Study (TSLS) in collaboration with researchers of the Harvard
Medical School under the support of the NIMH, U.S.A., to collect 600 families with at least
two siblings affected with schizophrenia. This data bank included DIGS, DNA and CPT as well
as WCST. This research team will use this data set to replicate the initial findings
obtained in this laboratory originally. This will be one major focus of the subsequent SEFOS
of this PPG.
All these data banks justify the abundant resource of data for continuous data analysis and
paper publication of this SEFOS of the PPG, and this is the reason that this SEFOS has to
set the core containing a statistical sub-core unit for the operation of data analysis. Up
to the present, this research team is mature enough to do continuous data analysis and
serial hypothesis testing. All these data provided the evidence that the grant of this SEFOS
will, apparently, achieve the expected results of this research team with great confidence.
6. The progress of the MPSS (July, 1998 – June 2001) till March, 2001 as the PPG of SEFOS
was proposed. Three sub-projects were reported to be as the following:
1) Phenomenological and neuropsychological manifestations of schizophrenia: a prospective
follow-up study.
(2) A family-genetic study of co-affected sib-pairs with schizophrenia. (3) Molecular
genetic study on schizophrenia using co-affected sib-pair and association strategies.
In conclusion, this MPSS has been going on smoothly in data collection as well as in data
analysis. The paper publication is going on steadily. These three sub-projects were
integrated and coordinated smoothly. Besides, the preliminary works using the
neurobiological technology of neurophysiology and brain Magnetic Resonance Spectrometry
(MRS) for measurements of psychopathological related manifestations have been performed.
These technologies were proved to be satisfactorily stable and applicable in
psychopathological study. The preliminary results were obtained and manuscripts were
prepared for submission. Actually, the technology can also be extended to the other brain
parts including the frontal region and the measurement of tractography is also available in
the imaging laboratory of the National Taiwan University Hospital.
The past tract record of the achievement of the smooth working infrastructure of this
research team leaded by the P.I. Hai-Gwo Hwu, including multidisciplinary specialists and
multi-institutes, the achievement of the advanced technologies of neurobiological
measurements related to the study of current psychopathological investigation of
schizophrenia, the previous achievement in psychopathological hypothesis testing and the
academic achievement of this research team, and the abundant data bank, highly justify that
this research team of the SEFOS of this PPG is a well cultivated research tem in
schizophrenia research. This SEFOS of PPG can positively be expected to have successful
results in the future if this team has this SEFOS grant for the coming 5 years of research
work.
